52 related articles for article (PubMed ID: 7536070)
1. Comparable outcomes of allogeneic peripheral blood versus bone marrow hematopoietic stem cell transplantation from a sibling donor for pediatric patients.
Kim BK; Hong KT; Choi JY; Kim H; Park HJ; Kang HJ
Ann Hematol; 2024 Jun; 103(6):2051-2058. PubMed ID: 38594416
[TBL] [Abstract][Full Text] [Related]
2. Aggressive non-Hodgkin's lymphoma: economics of high-dose therapy.
Beard SM; Wall L; Gaffney L; Sampson F
Pharmacoeconomics; 2004; 22(4):207-24. PubMed ID: 14974872
[TBL] [Abstract][Full Text] [Related]
3. Economic evaluations of granulocyte colony-stimulating factor: in the prevention and treatment of chemotherapy-induced neutropenia.
Esser M; Brunner H
Pharmacoeconomics; 2003; 21(18):1295-313. PubMed ID: 14750898
[TBL] [Abstract][Full Text] [Related]
4. Costs of peripheral blood progenitor cell transplantation using whole blood mobilised by filgrastim as compared with autologous bone marrow transplantation in non-Hodgkin's lymphoma.
Uyl-de Groot CA; Ossenkoppele GJ; Buijt I; Huijgens PC
Pharmacoeconomics; 1999 Mar; 15(3):305-11. PubMed ID: 10537437
[TBL] [Abstract][Full Text] [Related]
5. Autologous peripheral blood progenitor-cell transplantation versus autologous bone marrow transplantation for adults and children with non-leukaemic malignant disease. A randomised economic study.
Le Corroller AG; Faucher C; Auperin A; Blaise D; Fortanier C; Benhamou E; Hartmann O; Brosse JC; Maraninchi D; Moatti JP
Pharmacoeconomics; 1997 May; 11(5):454-63. PubMed ID: 10168033
[TBL] [Abstract][Full Text] [Related]
6. Filgrastim. A reappraisal of pharmacoeconomic considerations in the prophylaxis and treatment of chemotherapy-induced neutropenia.
Frampton JE; Faulds D
Pharmacoeconomics; 1996 Jan; 9(1):76-96. PubMed ID: 10161371
[TBL] [Abstract][Full Text] [Related]
7. Early infections after autologous transplantation for haematological malignancies.
Schiødt I; Bergmann OJ; Johnsen HE; Hansen NE
Med Oncol; 1998 Jul; 15(2):103-8. PubMed ID: 9789217
[TBL] [Abstract][Full Text] [Related]
8. High-dose chemotherapy followed by reinfusion of selected CD34+ peripheral blood cells in patients with poor-prognosis breast cancer: a randomized multicentre study.
Chabannon C; Cornetta K; Lotz JP; Rosenfeld C; Shlomchik M; Yanovitch S; Marolleau JP; Sledge G; Novakovitch G; Srour EF; Burtness B; Camerlo J; Gravis G; Lee-Fischer J; Faucher C; Chabbert I; Krause D; Maraninchi D; Mills B; Kunkel L; Oldham F; Blaise D; Viens P
Br J Cancer; 1998 Oct; 78(7):913-21. PubMed ID: 9764583
[TBL] [Abstract][Full Text] [Related]
9. Source of stem cells impacts on hematopoietic recovery after high-dose chemotherapy.
Zimmerman TM; Mick R; Myers S; Bender JG; Lee WJ; Williams SF
Bone Marrow Transplant; 1995 Jun; 15(6):923-7. PubMed ID: 7581092
[TBL] [Abstract][Full Text] [Related]
10. Comparison of G-CSF-primed peripheral blood progenitor cells and bone marrow auto transplantation: clinical assessment and cost-effectiveness.
Faucher C; le Corroller AG; Blaise D; Novakovitch G; Manonni P; Moatti JP; Maraninchi D
Bone Marrow Transplant; 1994 Dec; 14(6):895-901. PubMed ID: 7536070
[TBL] [Abstract][Full Text] [Related]
11. Comparison of G-CSF with GM-CSF for mobilizing peripheral blood progenitor cells and for enhancing marrow recovery after autologous bone marrow transplant.
Bolwell BJ; Goormastic M; Yanssens T; Dannley R; Baucco P; Fishleder A
Bone Marrow Transplant; 1994 Dec; 14(6):913-8. PubMed ID: 7536072
[TBL] [Abstract][Full Text] [Related]
12. G-CSF primed peripheral blood progenitor cells in autologous bone marrow transplantation: parameters affecting bone marrow engraftment.
Bolwell BJ; Fishleder A; Andresen SW; Lichtin AE; Koo A; Yanssens T; Burwell R; Baucco P; Green R
Bone Marrow Transplant; 1993 Dec; 12(6):609-14. PubMed ID: 7511016
[TBL] [Abstract][Full Text] [Related]
13. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
14. Comparative cost analysis of autologous peripheral blood progenitor cell and bone marrow transplantation in pediatric patients with malignancies.
Vicent MG; Madero L; Chamorro L; Madero R; Diaz MA
Haematologica; 2001 Oct; 86(10):1087-94. PubMed ID: 11602415
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
